Paper Information

Journal:   INTERNATIONAL JOURNAL OF PREVENTIVE MEDICINE   2014 , Volume 5 , Number 5; Page(s) 569 To 576.
 
Paper: 

REDUCING THE INCIDENCE OF CHRONIC LUNG DISEASE IN VERY PREMATURE INFANTS WITH AMINOPHYLLINE

 
 
Author(s):  ARMANIAN AMIR MOHAMMAD*, BADIEE ZOHREH, AFGHARI RAHA, SALEHIMEHR NIMA, HASSANZADEH AKBAR, SHEIKHZADEH SOGHRA, SHARIFTEHRANI MARYAM, REZVAN GOHAR
 
* NO. 133, SHAHID ANSARI ALLEY, SAEB STREET, POSTAL CODE: 8184757851, ISFAHAN, IRAN
 
Abstract: 

Background: The objective of this study is to assess the safety and preventative effects of aminophylline on the incidence of chronic lung disease (CLD) in very premature infants.
Methods: This was a long follow-up randomized clinical trial. The prophylactic effect of aminophylline on the incidence of CLD was investigated in very premature infants. The study group received aminophylline for the 1 st 10 days of life and control infants received no aminophylline during the 1 st 10 days of life.
Results: Fifty-two infants participated (26 aminophylline, 26 controls). Premature infants on aminophylline had clearly shorter oxygen dependency time than those in the control group. Median time of oxygen dependency was 3 (0-9.5) days and 14 (3-40.5) days in group A and C, respectively (P: 0.001). Incidence of CLD was significantly different between the two groups. Only two infants (8.7%) on aminophylline developed CLD, when compared to 11 infants (44.0%), who did not receive aminophylline (P: 0.006). No side-effects were reported in the neonates (P: 1).
Conclusions: This study supports the preventative effects of aminophylline on the incidence of CLD in very premature infants. In other words, the more premature the infants, the greater will be the preventative effect of aminophylline on the incidence of CLD.

 
Keyword(s): AMINOPHYLLINE, CHRONIC LUNG DISEASE, PRETERM NEONATES, PREVENTION
 
References: 
  • ندارد
 
  pdf-File tarjomyar Yearly Visit 31
 
Latest on Blog
Enter SID Blog